For members
Professional Recommendations
- Hepatology
- Gastroenterology
- Archived Professional Recommendations
- Standard Diagnostic and Therapeutic Outlines
Nonalcoholic Fatty Liver Disease
March 2017. Nonalcoholic fatty liver disease is currently considered the most common chronic liver disease. Therefore, on behalf of the Slovak Hepatology Society, we bring you the current recommendations for its diagnosis and treatment. Authors: Prof. Jozef Holomáň, MD, CSc.; Assoc. Prof. Mária Szántová, MD, PhD; Assoc. Prof. Martin Zima, MD, CSc.; Assoc. Prof. Tomáš Koller, MD, PhD; Ľubomíra Fábryová, MD, PhD.
Rational Diagnosis and Treatment of Hemochromatosis
Hereditary hemochromatosis is the most common hereditary disease in the Caucasian population. We have prepared a methodological sheet for you focused on this disease.
Methodological Sheet – Hepatic Encephalopathy, Diagnosis and Treatment 2017
Hepatic encephalopathy (HE) is one of the most serious complications of advanced liver disease. It reduces the quality of life for the patient and their surroundings. In patients with liver cirrhosis, HE is a manifestation of disease decompensation. It is associated with an increasing number of hospitalizations and affects patient mortality. Its economic and societal impact is significant. http://www.herba.sk/prezentacie/2017-ml-64-hepatalna-encelopatia-herba/2017-ml-64-hepatalna-encelopatia-herba.html
Rational Treatment of Chronic Non-Specific Inflammatory Bowel Diseases
July 2012. New scientific findings are the reason for updating professional recommendations in the spirit of "Evidence-Based Medicine" (EBM) principles. The last Methodological Sheet addressing the issue of rational pharmacotherapy for IBD was created in 2007.
Rational Diagnosis and Treatment of Celiac Disease
March 2009. Celiac disease (primary malabsorption syndrome, non-tropical sprue, gluten-sensitive enteropathy, gluten enteropathy) is a lifelong disease characterized by permanent autoimmune-mediated gluten intolerance, which leads to damage to the small intestinal mucosa and alteration of the immune system. The disease occurs in genetically predisposed individuals who consume prolamins found in wheat, rye, barley, and oats.
Rational Treatment of Gastroesophageal Reflux Disease
April 2005. Gastroesophageal Reflux Disease (GERD) is a condition caused by the repeated backflow of stomach contents from the stomach into the esophagus – gastroesophageal reflux. The regurgitating fluid (refluxate) is acidic in 90% of cases – containing hydrochloric acid (HCl) and pepsin. In about 10% of cases, it is an alkaline refluxate, which occurs when bile salts and pancreatic enzymes regurgitate from the duodenum into the stomach (duodenogastric reflux) and subsequently into the esophagus.
Diverticular Disease of the Colon – Diagnosis and Treatment
December 2016. The incidence of diverticulosis and diverticular disease of the colon is showing an upward trend worldwide. In these professional recommendations, we bring you an overview of current knowledge on the epidemiology, diagnosis, and treatment of this disease. Authors: Laura Gombošová, PhD; Assoc. Prof. Augustín Prochotský, MD, CSc.
Management of Chronic Hepatitis C Treatment with Triple Combination 3K-BOC (Archive)
July 2012. 54. Methodological sheet for rational pharmacotherapy. An older, now obsolete methodological sheet on the treatment of chronic hepatitis C with combination therapy including the first generation of protease inhibitors.
Management of Chronic Hepatitis C Treatment with Triple Combination 3K-TVR (Archive)
April 2012. 52. Methodological sheet for rational pharmacotherapy. An older, now obsolete methodological sheet on the treatment of chronic hepatitis C with combination therapy including the first generation of protease inhibitors.
Treatment and Prevention of Bleeding in Portal Hypertension
January 2008. In the context of this methodological sheet, the term "bleeding in portal hypertension" (BPH) refers to bleeding from the upper gastrointestinal tract (GIT) originating from lesions caused by portal hypertension (PHT). These include the following GIT lesions: esophageal varices (EV), gastric varices (GV), portal hypertensive gastropathy (PHG), and others (e.g., ectopic varices). This MS does not concern the treatment of bleeding complications of prehepatic portal hypertension.
Treatment of Chronic Viral Hepatitis B (Archive)
December 2004. Scientific progress in the field of CHB treatment has brought several new findings and changes in perspective: refinement of etiological diagnosis (primarily the use of PCR), introduction of interferons with a long biological half-life (pegylated interferons), and new molecules from the antiviral group (e.g., adefovir dipivoxil), which necessitated a reassessment of treatment indication criteria and monitoring requirements.
Treatment of Chronic Viral Hepatitis C (Archive)
November 2004. Historical methodological sheet on treatment before the advent of direct-acting antivirals.
Treatment of Chronic Viral Hepatitis B and C (Archive)
June 2001. Historical methodological sheet on the treatment of chronic hepatitis B and C from the turn of the millennium.
Rational Treatment of Chronic Non-Specific Inflammatory Bowel Diseases (Archive)
October 2007. Historical professional recommendations for the treatment of non-specific inflammatory bowel diseases.
Rational Treatment of Peptic Ulcer (Archive)
August 2000. Historical professional recommendations for the treatment of peptic ulcer.
Pharmacotherapy of Problematic Patient Groups with Chronic Hepatitis B, C, and D (Archive)
Methodological Sheet No. 7 – Year 1999.
Pharmacotherapy of Chronic Hepatitis B, D, and C with Interferon Alpha (Archive)
Methodological Sheet No. 3, Year 1998.
Diagnosis and Treatment of Hepatitis C with Dual Combination 2K
September 2013. Treatment of chronic hepatitis C with pegylated interferon and ribavirin is gradually moving into the background, but there are groups of patients where it is indicated. Authors: Ľubomír Skladaný, MD, PhD; Marián Oltman, MD, PhD; Prof. Jozef Holomáň, MD, CSc.
Center for Viral Hepatitis Treatment, 5th Internal Medicine Clinic of the Faculty of Medicine, Comenius University and University Hospital Bratislava
📞 0248234111
📍 Ružinovská 6, Bratislava
Center for Viral Hepatitis Treatment, Gastroentero-Hepatology Center THALION
✉️ dorkova@thalion.sk, kormancikova@thalion.sk
📞 +421 2/5710 8511, +421 911102107
📍 Tomášikova 50, 831 04 Bratislava
Center for Viral Hepatitis Treatment, HEGITO – Hepatology, Gastroenterology and Transplantation Department of the 2nd Internal Medicine Clinic SZU
✉️ hepato@nspbb.sk, jvnencakova@nspbb.sk, adropcova@nspbb.sk
📞 +421 48 441 2855 (Dept) / +421 48 441 3522 (Outpatient)
📍 FNsP F.D. Roosevelt, Námestie L. Svobodu 1, Banská Bystrica
Center for Viral Hepatitis Treatment, Hepatology Outpatient Clinic of the SZU Polyclinic, Bratislava
📞 0259370838
📍 Limbová 12, Bratislava
Center for Viral Hepatitis Treatment, 1st Internal Medicine Clinic SZU and UNB Dionýz Dieška
📞 (02) 5954 2256
📍 Limbová 5, 830 05 Bratislava
Center for Viral Hepatitis Treatment, 2nd Internal Medicine Clinic UN L. Pasteur and UPJŠ in Košice
📞 +421 55 6403424
📍 Trieda SNP 1, 04001 Košice
Center for Viral Hepatitis Treatment, 3rd Internal Medicine Clinic LFUK and UNB, Acad. L. Dérer Hospital
✉️ viera.kupcova@kr.unb.sk, maria.szantova@kr.unb.sk
📞 +421 2 59542370
📍 Limbová 5, 833 05 Bratislava
Center for Viral Hepatitis Treatment, Infectious Diseases Clinic of the Trnava Faculty Hospital
📞 0335938111
📍 A. Žarnova 11, Trnava
Center for Viral Hepatitis Treatment, Infectious Diseases Department of the F.D. Roosevelt Faculty Hospital with Polyclinic Banská Bystrica
📍 Nám. L. Svobodu 1, Banská Bystrica, 975 17
Center for Viral Hepatitis Treatment, Infectious Diseases Department of VšNsP in Lučenec
📞 047/4311413, 047/4311265
📍 Námestie republiky 15, 984 39 Lučenec
Center for Viral Hepatitis Treatment, Internal Medicine Clinic FNsP Nitra
📞 037/6545 492
📍 Špitálska 6, 950 01 Nitra
Center for Viral Hepatitis Treatment, Internal Medicine Department of the Faculty Hospital, Trenčín
📍 Legionárska 28, Trenčín
Center for Viral Hepatitis Treatment, Clinic of Infectology and Travel Medicine UN L. Pasteur Košice
📞 055 615 2202
📍 Rastislavova 43, 041 90 Košice
Center for Viral Hepatitis Treatment, Clinic of Infectology and Travel Medicine UNM
📞 +421 43 4203707
📍 Kollárova 2, 036 59 Martin
Center for Viral Hepatitis Treatment, Clinic of Infectology and Geographical Medicine LFUK, SZU and UNB
📞 02/5954 2951, 02/5954 2925
📍 Limbová 5, 833 05 Bratislava
Center for Viral Hepatitis Treatment, Clinic of Internal Medicine II, Hepatology Outpatient Clinic
📞 035 691 2380, 035 691 2717
📍 FNsP Nové Zámky, Slovenská 11A, 94034 Nové Zámky
Center for Viral Hepatitis Treatment, Department of Infectology FNsP J.A. Reiman Prešov
📞 051 7011330, 051 7011033
📍 Hollého 14, 081 81 Prešov
Trends in Hepatology
Trends in Hepatology 03/2018
Editorial - Assoc. Prof. Tomáš Koller, MD, PhD. The burden of alcohol-related diseases and EASL / ACO 2018 recommendations - Assoc. Prof. Mária Szántová, MD, PhD. Prevalence of hepatitis E virus infection in patients at the hepatology, gastroenterology and transplantation department (HEGITO) in Banská Bystrica - Ľubomír Skladaný, MD, PhD, h.doc; Svetlana Adamcová-Selčanová, MD; Zuzana Bečková, MD; Lenka Helmová, MD. New biomarkers in the diagnosis of chronic hepatitis B - Gabriela Rjašková, MD; Assoc. Prof. Pavol Kristian, MD, PhD; Prof. Ivan Schréter, MD, CSc.; Ivana Hockicková, MD, PhD. First European Conference of Young Gastroenterologists (ECYG) in Zagreb - Natália Bystrianska, MD; Ľudmila Bareková, MD.